7 results on '"Angelica Moresco"'
Search Results
2. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina
- Author
-
Gabriela Villanueva, Claudia Sampor, Florencia Moreno, Daniel Alderete, Angelica Moresco, Natalia Pinto, Irene Szijan, Paula Schaiquevich, María Sara Felice, Adriana Rose, Pedro Zubizarreta, Mariana Sgroi, Adriana Fandiño, and Guillermo Chantada
- Subjects
Leukemia ,Skin Neoplasms ,Adolescent ,Incidence ,Retinal Neoplasms ,Argentina ,Retinoblastoma ,Bone Neoplasms ,Breast Neoplasms ,Neoplasms, Second Primary ,Sarcoma ,Soft Tissue Neoplasms ,Sarcoma, Ewing ,Hematology ,Risk Assessment ,Central Nervous System Neoplasms ,Oncology ,Neoplasms ,Pediatrics, Perinatology and Child Health ,Humans ,Female ,Survivors ,Child - Abstract
Retinoblastoma survivors in low- and middle-income countries are exposed to high-intensity treatments that potentially place them at higher risk of early subsequent malignant neoplasms (SMNs).We followed 714 (403 [56.4%] nonhereditary and 311 [43.5%] hereditary) retinoblastoma survivors diagnosed from August 1987 to December 2016, up to the age of 16 years. We quantified risk of SMNs with cumulative incidence (CI) and standardized incidence ratios (SIR) analysis. Multivariate regression Cox model was used to determine the association of treatments and risk of SMNs.Median follow-up was of 9 years (range: 0.18-16.9) and 24 survivors (3.36%) developed 25 SMNs (n = 22 hereditary, n = 2 nonhereditary). SMNs included sarcomas (osteosarcomas, Ewing sarcomas, rhabdomyosarcomas; n = 12), leukemias (n = 5), and central nervous system tumors (CNS; n = 3). All cases of acute myeloid leukemia (AML) and most of Ewing sarcomas occurred within 5 years of retinoblastoma diagnosis. The type of SMN was the main indicator of mortality (five of five patients with leukemias, six of 12 with sarcomas, and zero of three with CNS tumors died). Compared to the general population, radiation increased the risk of Ewing sarcoma in hereditary survivors by 700-fold (95% CI = 252-2422.6) and chemotherapy increased the risk of AML by 140-fold (95% CI = 45.3-436). The CI of SMNs for hereditary survivors was 13.7% (95% CI = 8.4-22.1) at 15 years.Retinoblastoma survivors from Argentina are at higher risk of developing SMNs early in life compared to the general Argentinean population, especially those treated with radiation plus chemotherapy. AML and Ewing sarcoma presented within 5 years of retinoblastoma diagnosis are associated with chemotherapy and radiation exposure.
- Published
- 2022
- Full Text
- View/download PDF
3. Contributors
- Author
-
Michelle E. Abadingo, Marta Ascurra, Michelle Bishop, Kathleen Calzone, Eva Maria C. Cutiongco-de la Paz, Vajira H.W. Dissanayake, Ghada El-Kamah, Karen Fieggen, Clara L. Gaff, Desalyn L. Johnson, Bruce R. Korf, Dhavendra Kumar, Beatriz de la Fuente, Elly Lynch, Ebner Bon G. Maceda, Saqib Mahmood, Melissa Martyn, A. Middleton, Ximena Montenegro-Garreaud, Angelica Moresco, Helen Mountain, Amy Nisselle, Nicholas Pachter, Carmencita D. Padilla, Ratna Dua Puri, Victor Raggio, Simon Ramsden, J. Roberts, Augusto Rojas-Martinez, Anneke Seller, Alison Taylor-Beadling, Nilam Thakur, Emma Tonkin, and Rosa Pardo Vargas
- Published
- 2022
- Full Text
- View/download PDF
4. Preparing the workforce for genomic medicine: International challenges and strategies
- Author
-
Desalyn L. Johnson, Bruce R. Korf, Marta Ascurra, Ghada El-Kamah, Karen Fieggen, Beatriz de la Fuente, Saqib Mahmood, Augusto Rojas-Martinez, Ximena Montenegro-Garreaud, Angelica Moresco, Helen Mountain, Nicholas Pachter, Ratna Dua Puri, Victor Raggio, Nilam Thakur, and Rosa Pardo Vargas
- Abstract
Medical genetics has historically focused on the management of rare disorders, mostly due to variants in single genes or chromosomes. Advances in genomics, however, are leading to the capability of including genomic approaches more broadly into the prevention, diagnosis, and treatment of both rare and common disorders. There is a well-established genetics workforce in many parts of the world, particularly in higher-income countries, though this workforce is neither large enough nor widely enough distributed to fuel the integration of genomics across all of medicine. This chapter will review the status of genetics training in various parts of the world and the opportunities and needs for expansion of training into genomic medicine.
- Published
- 2022
- Full Text
- View/download PDF
5. Variability in Phelan-McDermid Syndrome in a Cohort of 210 Individuals
- Author
-
Julián Nevado, Sixto García-Miñaúr, María Palomares-Bralo, Elena Vallespín, Encarna Guillén-Navarro, Jordi Rosell, Cristina Bel-Fenellós, María Ángeles Mori, Montserrat Milá, Miguel del Campo, Pilar Barrúz, Fernando Santos-Simarro, Gabriela Obregón, Carmen Orellana, Harry Pachajoa, Jair Antonio Tenorio, Enrique Galán, Juan C. Cigudosa, Angélica Moresco, César Saleme, Silvia Castillo, Elisabeth Gabau, Luis Pérez-Jurado, Ana Barcia, Maria Soledad Martín, Elena Mansilla, Isabel Vallcorba, Pedro García-Murillo, Franco Cammarata-Scalisi, Natálya Gonçalves Pereira, Raquel Blanco-Lago, Mercedes Serrano, Juan Dario Ortigoza-Escobar, Blanca Gener, Verónica Adriana Seidel, Pilar Tirado, Pablo Lapunzina, Spanish PMS Working Group, Mena Rocío, Lleguer Roser, Fernández-Montaño Victoria, Martín Rubén, Fernández Blanca, García-Santiago Fé, Gómez del Pozo Victoria, Peña Carolina, Alhambra Norma, García Carlos, Rodríguez Juan Ramón, Martínez-Bermejo Antonio, Málaga Ignacio, Martínez-Monseny Antonio Federico, Armstrong Judith, Anticona Jennifer, Hernando-Davalillo Cristina, San Martí Adrián Alcalá, Martorell Loreto, Yubero Delia, Nunes Tania, Callaghan Mar O´, Alonso Xenia, Ramos Federico, López Jesús Casas, López-González Vanesa, M Juliana Ballesta, Armengol Lluís, González-Meneses Antonio, Borrego Salud, Roselló Mónica, Suela Javier, Pérez-Granero Ángeles, and Rodríguez-Revenga Laia
- Subjects
autistic behavior ,22q13 deletion syndrome ,Phelan-McDermid syndrome (PMS) ,SHANK3 ,subtelomeric deletion syndrome ,intellectual disabilities (ID) ,Genetics ,QH426-470 - Abstract
Phelan-McDermid syndrome (PMS, OMIM# 606232) results from either different rearrangements at the distal region of the long arm of chromosome 22 (22q13.3) or pathogenic sequence variants in the SHANK3 gene. SHANK3 codes for a structural protein that plays a central role in the formation of the postsynaptic terminals and the maintenance of synaptic structures. Clinically, patients with PMS often present with global developmental delay, absent or severely delayed speech, neonatal hypotonia, minor dysmorphic features, and autism spectrum disorders (ASD), among other findings. Here, we describe a cohort of 210 patients with genetically confirmed PMS. We observed multiple variant types, including a significant number of small deletions (
- Published
- 2022
- Full Text
- View/download PDF
6. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome
- Author
-
Roxana Marino, Angélica Moresco, Natalia Perez Garrido, Pablo Ramirez, and Alicia Belgorosky
- Subjects
congenital adrenal hyperplasia ,CAH-X ,CYP21A2 ,TNXB ,Ehlers-Danlos Syndrome ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Congenital adrenal hyperplasia (CAH) secondary to 21-hydroxylase deficiency is an autosomal recessive disorder. The 21-hydroxylase enzyme P450c21 is encoded by the CYP21A2 gene located on chromosome 6p21.33 within the HLA major histocompatibility complex. This locus also contains the CYP21A1P, a non-functional pseudogene, that is highly homologous to the CYP21A2 gene. Other duplicated genes are C4A and C4B, that encode two isoforms of complement factor C4, the RP1 gene that encodes a serine/threonine protein kinase, and the TNXB gene that, encodes the extracellular matrix glycoprotein tenascin-X (TNX). TNX plays a role in collagen deposition by dermal fibroblasts and is expressed in the dermis of the skin and the connective tissue of the heart and skeletal muscle. During meiosis, misalignment may occur producing large gene deletions or gene conversion events resulting in chimeric genes. Chimeric recombination may occur between TNXB and TNXA. Three TNXA/TNXB chimeras have been described that differ in the junction site (CH1 to CH3) and result in a contiguous CYP21A2 and TNXB gene deletion, causing CAH-X syndrome. TNXB deficiency is associated with Ehlers Danlos syndrome (EDS). EDS comprises a clinically and genetically heterogeneous group of connective tissue disorders. As molecular analysis of the TNXB gene is challenging, the TNX-deficient type EDS is probably underdiagnosed. In this minireview, we will address the different strategies of molecular analysis of the TNXB-gene, as well as copy number variations and genetic status of TNXB in different cohorts. Furthermore, clinical features of EDS and clinical recommendations for long-term follow-up are discussed.
- Published
- 2022
- Full Text
- View/download PDF
7. Efecto de la altitud sobre el peso al nacer y eventos perinatales adversos en dos poblaciones argentinas
- Author
-
Carlos Grandi, José Dipierri, Guillermo Luchtenberg, Angélica Moresco, and Emma Alfaro
- Subjects
altitud ,hipoxia ,peso al nacer ,retardo del crecimiento fetal ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introducción: existe poca información sobre la relación entre tamaño al nacer y altura geográfica ajustada para factores maternos y obstétricos potencialmente confusores. Objetivo: analizar la variación, en función de la altitud geográfica, del Peso al Nacimiento (PN) y resultados perinatales adversos, en dos poblaciones argentinas. Material y Métodos: 4000 registros de recién nacidos (RN) de Jujuy y 4000 de Buenos Aires (Maternidad Sardá) (1996-2000), seleccionados y aleatorizados del Sistema Informático Perinatal. Los datos provenían de la Maternidad Sarda (20 msnm) y las regiones jujeñas: Ramal (500 msnm), Valle (1200 msnm), Quebrada (2500 msnm) y Puna (3500 msnm). Variables resultado: PN >3000 g, PN 3000 g, PN
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.